Kyntra Bio

Contributing Author

Recent Articles by Kyntra Bio

Jun-11	Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes KYNB KYNB +5.47% GlobeNewswire
May-11	Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update KYNB KYNB +6.25% GlobeNewswire
May-04	Kyntra Bio to Report First Quarter 2026 Financial Results KYNB GlobeNewswire
Apr-08	Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference KYNB +5.49% GlobeNewswire
Mar-16	Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update KYNB KYNB +5.29% GlobeNewswire
Mar-09	Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results KYNB +7.31% GlobeNewswire
Feb-23	Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026 KYNB KYNB -9.57% GlobeNewswire
Feb-17	Kyntra Bio to Participate in Upcoming Investor Conferences KYNB KYNB +6.28% GlobeNewswire